Internal Medicine · Warner Robins, GA
NPI
1316997489
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
301 Osigian Blvd
Warner Robins, GA, 31088
Phone (478) 971-2130
Groups this clinician bills Medicare through
Medicare paid, 2024
$266K
5,236 services
Medicare patients, 2024
525
Average age 74
Drug cost, 2024
$2.7M
18,590 prescriptions
Company payments, 2025
$1,403
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maher A Abdulla was code 99214 (office e&m - established), 2,218 times for 467 patients. In total Maher A Abdulla billed 5,236 services in 63 codes, and Medicare paid $266K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,218 | 467 | $80.15 | $178K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 754 | 138 | $0.08 | $59.65 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 396 | 87 | $0.30 | $120 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 333 | 333 | $117.02 | $39K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 321 | 321 | $17.13 | $5,499 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 316 | 316 | $17.13 | $5,414 |
| 96372 Injection Administration | Office | 214 | 147 | $9.24 | $1,977 |
| 71046 X-ray - Chest | Office | 99 | 91 | $18.46 | $1,827 |
| 93306 Echocardiography (TTE/TEE) | Office | 91 | 91 | $80.89 | $7,361 |
| 99213 Office E&M - Established | Office | 74 | 69 | $57.57 | $4,260 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 59 | 15 | $0.10 | $6.05 |
| 93000 Electrocardiogram | Office | 37 | 37 | $9.67 | $358 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 35 | 30 | $149.68 | $5,239 |
| 20610 Joint Injection | Office | 33 | 19 | $50.47 | $1,665 |
| 99212 Office E&M - Established | Office | 22 | 18 | $29.43 | $648 |
By year: 2022 $327K for 6,327 services; 2023 $269K for 5,781 services; 2024 $266K for 5,236 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 21 | 16 | $1.89 | $39.67 |
| 81003 Clinical Chemistry | 16 | 16 | $2.25 | $36 |
Medicare prescription drug claims, 2024
In 2024, the drug Maher A Abdulla prescribed most often to Medicare patients was Rosuvastatin Calcium, with 946 prescriptions and refills. In total Maher A Abdulla wrote 18,590 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 946 | 2,426 | 252 | $9,786 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 624 | 626 | 129 | $10K |
| Losartan Potassium Generic | 584 | 1,500 | 159 | $5,629 |
| Omeprazole Generic | 524 | 1,316 | 151 | $6,478 |
| Levothyroxine Sodium Generic | 492 | 1,330 | 142 | $6,542 |
| Gabapentin Generic | 486 | 780 | 107 | $9,151 |
| Atorvastatin Calcium Generic | 388 | 1,040 | 116 | $2,781 |
| Amlodipine Besylate Generic | 376 | 984 | 103 | $1,944 |
| Ozempic Semaglutide | 374 | 556 | 80 | $474K |
| Alprazolam Generic | 360 | 366 | 87 | $948 |
| Metoprolol Succinate Generic | 338 | 732 | 84 | $5,506 |
| Mounjaro Tirzepatide | 328 | 431 | 68 | $455K |
| Pantoprazole Sodium Generic | 303 | 741 | 75 | $2,628 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 273 | 273 | 44 | $7,528 |
| Famotidine Generic | 258 | 588 | 85 | $3,350 |
Brand drugs: 2,484 claims; generic drugs: 16,059 claims; opioid claims: 1,249.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maher A Abdulla $1,403 ($1,403 in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $350.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 15 | $350 |
| Abbvie Inc. ABBV | 10 | $224 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $152 |
| Astellas Pharma US Inc 4503.T | 5 | $125 |
| Pfizer Inc. PFE | 3 | $64.06 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $63.09 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $52.21 |
| Lilly USA, LLC LLY | 3 | $51.96 |
| Noven Therapeutics, LLC | 2 | $44.72 |
| Amgen Inc. AMGN | 2 | $32.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.